http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cryoport and Inception Fertility Enter Into Agreement
-
Cryoport (CYRX) Announces Preliminary Q4 Revenue
-
Cryoport Announces Preliminary Fourth Quarter and Full Year 2019 Revenue
-
Cryoport Revenue Grows 81% for Third Quarter 2019
-
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019
-
Cryoport (CYRX) Authorizes $15M Share Repurchase Program
-
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences
-
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
-
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies
-
Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market
-
Cryoport Revenue Grows 83% for Second Quarter 2019
-
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
-
Cryoport (CYRX), EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
-
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
-
Cryoport to Ring the Nasdaq Closing Bell on Monday, June 10 and Attend Jefferies 2019 Healthcare Conference June 4ᵗʰ-7ᵗʰ, 2019
-
CalAmp Announces Research Collaboration with Cryoport to Develop Next Generation Condition Monitoring System
-
Cryoport (CYRX) Reports Acquisition of Cryogene
-
Cryoport Expands into Biostorage through the Acquisition of Cryogene
-
Cryoport to Host Workshop at 14th Annual World Advanced Therapies & Regenerative Medicine Congress on Wednesday, May 15th
-
Cryoport Revenue Grows 65% for First Quarter 2019
-
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
-
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
-
Biokin Pharmaceutical Selects Cryoport's Temperature-Controlled Solutions for its Pending Phase I and Phase II trials
-
Cryoport Reports 64% Growth for Fiscal Year 2018
-
Cryoport to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7th, 2019
-
Cryoport Opens Global Logistics Center in Amsterdam
-
Dacos A/S Partners with Cryoport to Offer Full Suite of Temperature-Controlled Logistics Solutions to Global Client Base
-
Cryoport (CYRX) Announces Daniel M. Hancock to Board
-
Cryoport Appoints Daniel M. Hancock to Board of Directors
-
Cryoport Announces $25 Million Investment from Petrichor Healthcare Capital Management
-
Cryoport Revenue Grows 76% for Third Quarter 2018; 91% Growth in Biopharma
-
Cryoport to Report Third Quarter 2018 Financial Results on November 8th, 2018
-
Cryoport Celebrates Grand Opening of its Global Logistics Center In New Jersey with Ribbon Cutting Ceremony
-
Be The Match BioTherapies® and Cryoport Announce Strategic Partnership to Deliver Integrated End-to-End Supply Chain Services to the Cell and Gene Therapy Industry
-
Be The Match BioTherapies® and Cryoport Announce Strategic Partnership to Deliver Integrated End-to-End Supply Chain Services to the Cell and Gene Therapy Industry
-
Cryoport Revenue Grows 59% for Second Quarter 2018; 73% in Biopharma
-
Cryoport Launches CryoStork℠ Insurance to Support IVF Logistics Solutions
-
Cryoport to Report Second Quarter 2018 Financial Results on August 9th, 2018
-
Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market
-
Cryoport Delivers Biological Samples for International Space Station; Rocket Launched Today Arrives at International Space Station on Monday
-
Cryoport Set to Join Russell 3000 Index and Russell 2000 Index
-
Cryoport Revenue Grows 48% for First Quarter; 62% in Biopharma
-
Cryoport to Report First Quarter 2018 Financial Results on May 3rd, 2018
-
Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017
-
McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies
-
Cryoport to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 6th, 2018
-
Cryoport to Provide DiscGenics with Cutting Edge Cold Chain Logistics Support for its Phase 1/2 Trial
-
Cryoport To Provide TiGenix With Cutting Edge Cold Chain Logistics for Clinical Trial of SEPCELL for the Treatment of Sepsis
-
The Cryoport Biotech Activity Index Decreases 7.1% In Third Quarter of 2017; While the Total Number of Clinical Trials Increases to 934 Worldwide
-
Cryoport Revenue Up 52%; Driven by BioPharma

